Bio-Rad Laboratories | BIO - Gewinn Vor Steuern

Aktienkurs
287.86
Täglich Wechseln
6.81 2.42%
Monatlich
-5.83%
Jährlich
26.02%
Q2 Prognose
242.55




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Danaher USD 1.24B 138M 2026-03
General Electric Aerospace USD 2.2B 654M 2026-03
Illumina USD 157M 220M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Merck USD 3.42B 3.32B 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Siemens EUR 2.94B 559M 2025-12
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tosoh JPY 29.77B 1.16B 2026-03
Waters USD 264.18M 94.06M 2025-12